ストックスクリーナーアプリを入手
2.55
11.84%
0.27
アフターアワーズ：
2.48
-0.07
-2.75%
前日終値:
$2.28
開ける：
$2.17
24時間の取引高:
8.18M
Relative Volume:
2.60
時価総額：
$88.60M
収益：
-
当期純損益:
$-10.58M
株価収益率:
-2.125
EPS:
-1.2
ネットキャッシュフロー:
$-9.21M
1週間 パフォーマンス:
+83.45%
1か月 パフォーマンス:
+65.58%
6か月 パフォーマンス:
+164.41%
1年 パフォーマンス:
+147.57%
1日の値動き範囲:
$2.13
$2.60
1週間の範囲:
$1.48
$2.60
52週間の値動き範囲:
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
名前
Microbot Medical Inc
セクター
電話
908-938-5561
住所
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
MBOT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.55 | 88.60M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
488.27 | 174.93B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
202.04 | 58.01B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.42 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.97 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
77.80 | 15.49B | 3.90B | 392.30M | 288.10M | 1.95 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-01-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-31 | 開始されました | Ladenburg Thalmann | Buy |
Microbot Medical Inc (MBOT) 最新ニュース
Microbot Medical modifies shareholder meeting quorum - Investing.com
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care - TradingView
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Stock Soars: Is the Rally Sustainable? - timothysykes.com
Microbot Medical Presents Successful Trial Results for LIBERTY System - TipRanks
Microbot Medical stock rises on trial win (MBOT:NASDAQ) - Seeking Alpha
Microbot Medical® Shares Results From Its Pivotal Clinical Trial - MarketScreener
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic ... - Bluefield Daily Telegraph
Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire
Groundbreaking Clinical Trial: New Robotic System Cuts Surgeon Radiation by 92% - Stock Titan
Microbot Medical (NASDAQ:MBOT) Shares Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Microbot Medical to Present ACCESS-PVI Trial Data - TipRanks
REMINDER: Microbot Medical Announces Data from the - GlobeNewswire
Groundbreaking Clinical Trial Results: Revolutionary Endovascular Robot Faces Critical FDA Decision - Stock Titan
Microbot Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Microbot Medical Inc. (MBOT) reports earnings - Quartz
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
MICROBOT MEDICAL Earnings Preview: Recent $MBOT Insider Trading, Hedge Fund Activity, and More - Nasdaq
Microbot Medical Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - Defense World
Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Microbot Medical Stock Price, Quotes and Forecasts | NASDAQ:MBOT - Benzinga
Microbot Medical names Paul Mullen as VP, sales - Medical Buyer
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints New VP Ahead of Product Launch - TipRanks
Microbot Medical appoints Paul Mullen as VP, sales - TipRanks
Microbot Medical Appoints Seasoned Endovascular Sales Executive To Lead Its U.S. Sales Activities For LIBERTY® Endovascular Robotic System - MENAFN.COM
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical Inc. and Corewell Health Are Working Together to Advance Robotic Telesurgery for Endovascular Applications - Marketscreener.com
Microbot Medical's LIBERTY System Data On Robotic Telesurgery To Be Presented At CRT 2025 - Nasdaq
Microbot Medical Advances in Robotic Telesurgery Research - TipRanks
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting - The Manila Times
Microbot Medical Inc. and Corewell Health™ Achieve Milestone in Robotic Telesurgery Collaboration - Nasdaq
Microbot Medical Inc (MBOT) 財務データ
収益
当期純利益
現金流量
EPS
2.76%
大文字化:
|
ボリューム (24 時間):